Advertisements


Decoding cancer: Hopes rise for a new age of precision medicine

Treatments targeting the molecular features of a tumor could usurp chemotherapy — but at a price......»»

Category: topSource: bizjournalsOct 13th, 2017

What they said: Leaders in precision medicine set hopes on future advancements

Leaders in precision medicine set hopes on future advancements.....»»

Category: topSource: bizjournalsSep 1st, 2017

What happened to precision medicine?

Precision medicine isn't being used for all cancer patients — yet.....»»

Category: topSource: bizjournalsSep 1st, 2017

Novartis Profit Dented by Investment in New Drugs

Novartis said profit fell in the first quarter as it pumped investment into the launch of its new heart-failure drug Entresto that it hopes will help offset revenue lost as best-selling cancer medicine Gleevec loses out to cheaper competitors......»»

Category: smallbizSource: wsjApr 25th, 2017

UCSF"s $275M cancer center set to break ground in Mission Bay next month

The $275 million UC San Francisco Precision Cancer Medicine Building will break ground next month, the latest project approved in the university’s massive Mission Bay expansion. Construction on the 170,000-square-foot facility located on the Sout.....»»

Category: topSource: bizjournalsMar 15th, 2017

How Precision Medicine Could Be A Lifesaver For Kids With Brain Cancer

N.....»»

Category: smallbizSource: forbesJan 19th, 2017

SAPVoice: Precision Medicine Gives People With Cancer New Hope In 2017

When it comes to something as deeply personal and emotionally powerful as a cancer diagnosis, few people are satisfied with a one-size-fits-all treatment plan. Welcome to the next phase of prec.....»»

Category: smallbizSource: forbesJan 18th, 2017

Drug costs skyrocket for many older Americans, despite Medicare coverage

To avoid liver damage, Roberta Solar, a 71-year-old cancer patient, has to take a medicine called ursodiol, perhaps for the rest of her life. Next year her annual out-of-pocket costs for the drug will jump from $93 to $1,878 – a rise of almost 2,000%, a.....»»

Category: topSource: latimesNov 23rd, 2016

US Industrial Production Data Dashes "Survey-Driven" Hopes Of Manufacturing Renaissance

Following August's storm-driven collapse in Industrial Production (-0.9%, worst since May'09), September was due for a bounce back and it did but only meeting expectations with a 0.3% rise on a surge in Utilities. H.....»»

Category: blogSource: zerohedge22 hr. 58 min. ago

With $43M haul, Atlas-backed startup applies precision medicine to eye disease

A new biotech startup has scored $42.5 million in financing from Atlas Venture and other prominent investors as it looks to develop treatments for the leading cause of irreversible blindness in the U.S. Cambridge-based Gemini Therapeutics came out of.....»»

Category: topSource: bizjournalsOct 17th, 2017

30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine

Ana Pelisson/Business Insider It's an exciting time to be in the biotech and pharmaceutical industries. From advances in cancer treatments to using genomics to better understand diseases, to technologies that let you edit, silence, or.....»»

Category: topSource: businessinsiderOct 15th, 2017

Using Artificial Intelligence to Find Cancer Cures

A Baltimore-based biotech research company hopes to revolutionize drug development by slashing the time necessary for research......»»

Category: topSource: newsweekOct 12th, 2017

Why America’s Exploding Teen Obesity Crisis Is Bad News for U.S. Health Care

The rise of obesity means the rise of cancer, he.....»»

Category: europeSource: fortuneOct 11th, 2017

Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine

Ana Pelisson/Business Insider It's an exciting time to be in the biotech and pharmaceutical industries. From advances in cancer treatments to using genomics to better understand diseases, to technologies that le.....»»

Category: topSource: businessinsiderOct 9th, 2017

London Markets: U.K. stocks log slight gains as bank shares rally on interest-rate hopes

Bank stocks stood out in an otherwise listless U.K. stock market and advanced on Thursday, boosted by expectations that interest rates soon will rise in both Britain and the U.S......»»

Category: topSource: marketwatchSep 28th, 2017

Pfizer helps pump $103M into startup to develop new cancer therapies

A New York startup has been spun-out of Pfizer to develop clinical-stage experimental therapies. Nascent medicine company SpringWorks Therapeutics completed a $103 million series A round led by the New York-based pharma giant with the help of Bain.....»»

Category: topSource: bizjournalsSep 26th, 2017

Some NFL players want a month for social justice similar to "Breast Cancer Awareness Month"

A group of four prominent NFL players reached out to the league in hopes of securing support for social activism and community involvement, according t.....»»

Category: topSource: businessinsiderSep 21st, 2017

Futures Movers: Oil climbs as U.S. crude supplies rise, but OPEC output-cut hopes prevail

Oil prices climb toward the highest levels in months Wednesday as expectations that OPEC will decide to extend its production-cut deal outweighed pressure from a third-straight weekly jump in U.S. crude supplies and a hefty rise in production......»»

Category: topSource: marketwatchSep 20th, 2017

China Rushes to Surpass U.S. in Decoding Citizens" Genes

Beijing sets the goal of collecting and analyzing the genetic data from at least 1 million Chinese citizens to help unearth the causes of diseases from cancer to schizophrenia, and pave the way for targeted treatments......»»

Category: topSource: wsjSep 20th, 2017

Costly drugs to weigh on U.S. employers" expenses in 2018: survey

(Reuters) - U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer......»»

Category: topSource: reutersSep 18th, 2017

Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?

The FDA approved the first cancer medicine "biosimilar" Thursday.....»»

Category: europeSource: fortuneSep 15th, 2017